Skip to main content

Table 2 Univariate linear regression analysis of factors associated with LVMI

From: Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study

 

LVMI after 6 months of dialysis (univariate analysis)

 

Regression coefficients

Standard error

β

p-value

Age

1.941

0.776

0.543

0.024

Sex: male

56.234

22.901

0.535

0.027

Baseline Hb

-15.131

11.080

-0.333

0.192

After 6 months of dialysis

 Weight

-0.599

1.080

-0.147

0.588

 Systolic blood pressure

-0.414

1.055

-0.108

0.701

 Diastolic blood pressure

-1.112

0.825

-0.350

0.201

 Hemoglobin

-26.910

8.466

-0.634

0.006

 ERI

-0.249

0.738

-0.090

0.741

 TSAT

-191.513

81.409

-0.597

0.040

 Ferritin

-0.089

0.117

-0.235

0.462

 BNP

0.130

0.028

0.840

0.001

 Intact PTH

0.026

0.087

0.094

0.771

 Correct calcium

-28.354

29.733

-0.319

0.368

 Phosphorus

-2.779

15.001

-0.065

0.858

 Mean Hb

-30.969

13.765

-0.502

0.040

  1. β: Standardized regression coefficients
  2. Abbreviations: BNP Brain natriuretic peptide, PTH Parathyroid hormone, hsCRP High-sensitivity C reactive protein, TSAT Transferrin saturation, Hb Hemoglobin, ERI Erythropoietin resistance index, LVMI Left ventricular mass index